References
- Gold WM. Neurohumeral interactions in airways. Am Rev Respir Dis 1977: 115(6 Pt 2): 127–37
- Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy Clin Immunol 1968: 42(Oct): 203–32
- Empey DW, Laitenen LA, Jacobs L, et al. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976: 113(2): 131–9
- Spannhake EW, Hyman AL, Kadowitz PJ. Bronchoactive metabolites of arachidonic acid and their role in airway function. Prostaglandins 1981: 22(6): 1013–26
- Kay AB. Basic mechanisms in alleigic asthma. Eur J Respir Dis (Suppl) 1982: 122: 9–16
- Ford-Hutchinson AW, Bray MA, Doig MV, et al. Leukotriene B. a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980: 286(5770): 264–5
- Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981: 289(5799): 646–50
- Morris HR, Taylor GW, Piper PJ, et al. Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature 1980: 285(5760): 104–6
- Holroyde MC, Altounyan RE, Cole M. et al. Bronchoconstriction produced in man by leukotrienes C and D. Lancet 1981: 2(8236): 17–8
- Barnes NC, Piper PJ, Costello JF. Comparative effects of inhaled leukotriene C4, leukotriene D4 and histamine in normal subjects. Thorax 1984: 39(7): 500–4
- Griffin M, Weiss JW, Leitch AG, et al. Effects of leukotriene D on the airways in asthma. N Engl J Med 1983: 308(8): 436–9
- Barnes NC. Piper PJ, Costello JF. Actions of inhaled leukotrienes and their interactions with other allergic mediators. Prostaglandins 1984: 28(3)
- Smith LJ, Patterson R, Greenberger P, et al. Airway response to inhaled leukotriene D4 in man. (Abstr) Am Rev Respir Dis 1984: 129(4 Pt 2): A1
- Marom Z. Shelhamer JH, Bach MK, et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982: 126(3): 449–51
- Lewis RA, Soter NA, Diamond PT, et al. Prostaglandin D2 generation after activation of rat and human mast cells in anti-IgE. J Immunol 1982: 129(4): 1627–31
- Hardy C, Robinson C, Tattersfield AE, et al. The bronchoconstrictor effect of inhaled Prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984: 311(4): 209–13
- Heaton RW, Henderson AF, Dunlop LS, et al. The influence of pre-treatment with Prostaglandin F20 as bronchial sensitivity to inhaled histamine and methacholine in normal subjects. Br J Dis Chest 1984: 78(2): 168–73
- Hyman AL, Kadowitz PJ. Vasodilator actions of Prostaglandin 6-keto-E1 in the pulmonary vascular bed. J Pharmacol Exp Ther 1980: 213(3): 468–72
- Zakrzewski JT, Barnes NC, Piper PJ, et al. Sputum leukotrienes and Prostanoids: possible synergistic mediators in cystic fibrosis. bronchiectasis or chronic bronchitis. Prostaglandins 1984: 28(3)
- Henderson AF, Heaton RW, Dunlop LS, et al. Effects of nifedipine on antigen-induced bronchoconstriction. Am Rev Respir Dis 1983: 127(5): 549–53